Success Metrics

Clinical Success Rate
93.3%

Based on 28 completed trials

Completion Rate
93%(28/30)
Active Trials
3(7%)
Results Posted
32%(9 trials)
Terminated
2(5%)

Phase Distribution

Ph early_phase_1
1
2%
Ph not_applicable
7
17%
Ph phase_4
11
26%
Ph phase_2
4
10%
Ph phase_1
9
21%
Ph phase_3
9
21%

Phase Distribution

10

Early Stage

4

Mid Stage

20

Late Stage

Phase Distribution41 total trials
Early Phase 1First-in-human
1(2.4%)
Phase 1Safety & dosage
9(22.0%)
Phase 2Efficacy & side effects
4(9.8%)
Phase 3Large-scale testing
9(22.0%)
Phase 4Post-market surveillance
11(26.8%)
N/ANon-phased studies
7(17.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

28 of 35 finished

Non-Completion Rate

20.0%

7 ended early

Currently Active

3

trials recruiting

Total Trials

42

all time

Status Distribution
Active(4)
Completed(28)
Terminated(7)
Other(3)

Detailed Status

Completed28
Withdrawn5
unknown3
Recruiting3
Terminated2
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
42
Active
3
Success Rate
93.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (2.4%)
Phase 19 (22.0%)
Phase 24 (9.8%)
Phase 39 (22.0%)
Phase 411 (26.8%)
N/A7 (17.1%)

Trials by Status

completed2867%
unknown37%
withdrawn512%
enrolling_by_invitation12%
recruiting37%
terminated25%

Recent Activity

Clinical Trials (42)

Showing 20 of 42 trialsScroll for more
NCT07568574Not Applicable

Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes

Enrolling By Invitation
NCT06253702Phase 4

Brain Blood Flow Responses to Stress: Sex Differences

Completed
NCT04833426Phase 3

Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomy

Recruiting
NCT06294990Phase 4

Klinefelter Syndrome and Testosterone Treatment in Puberty

Recruiting
NCT06393634Early Phase 1

Comparing Direct and Indirect Detection Methods of Multiple Routes of Testosterone Administration

Completed
NCT02758431Not Applicable

Cardiovascular Outcomes of Low Testosterone

Completed
NCT02418572Phase 3

Testosterone TRANSdermal Gel for Poor Ovarian Responders Trial

Terminated
NCT05586802Phase 3

Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndrome

Recruiting
NCT00587431Phase 2

Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer

Completed
NCT00398034Phase 2

Analgesic Efficacy of Testosterone Replacement in Hypogonadal Opioid-treated Chronic Pain Patients: A Pilot Study.

Withdrawn
NCT00612742Phase 3

Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women

Completed
NCT04831099Phase 3

Testosterone Treatment in a Patient With 17β-hydroxysteroid Dehydrogenase Type 3 Deficiency: an N-of-1 Study

Unknown
NCT04819204Not Applicable

Testosterone and Neurovascular Control in Humans

Unknown
NCT04602143Not Applicable

Effect of Testosterone Pretreatment in POR

Completed
NCT03176537Phase 4

Periodontal Profile of Hypogonadic Men

Withdrawn
NCT04336891

Effect of Testosterone Treatment on Clitoral Arteries' Hemodynamic Parameters.

Completed
NCT04166786Phase 1

Steroid Profile: Differentiating Testosterone Administration From (Simultaneous) Ethanol Consumption

Completed
NCT00957801Phase 4

Anabolic and Inflammatory Responses to Short-Term Testosterone Administration in Older Men

Completed
NCT00194675Phase 4

TRADE-Testosterone Replacement and Dutasteride Effectiveness

Completed
NCT03289559Not Applicable

Effects of Testosterone and Fat Utilization

Completed

Drug Details

Intervention Type
DRUG
Total Trials
42